Literature DB >> 1973694

Does an adequate control of blood pressure protect the kidney in essential hypertension?

L M Ruilope1, J M Alcazar, E Hernandez, F Moreno, M A Martinez, J L Rodicio.   

Abstract

We analyzed the clinical course of 120 patients who were diagnosed as having primary hypertension and subsequently given standard stepped-care therapy (diuretic, beta-blocker and vasodilator) for 9 years. At the end of the follow-up period, 21 patients (17.5%) had developed overt proteinuria. The initial study showed no difference in systolic blood pressure, age, sex, serum creatinine and its clearance, glucose, cholesterol and triglycerides between these patients and those who had not become proteinuric, but uric acid levels and diastolic blood pressure were higher (both P less than 0.01). An adequate control of blood pressure was obtained and maintained in all patients, who had similar therapeutic needs. During the follow-up period, uric acid levels remained significantly elevated (P less than 0.01) in the proteinuric patients, while changes in serum glucose, cholesterol and triglycerides were similar in all patients. These results indicate that long-term treatment of primary hypertensives does not fully protect kidney function and that initially elevated uric acid levels could be a predictor of a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973694     DOI: 10.1097/00004872-199006000-00005

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Treatment of patients with essential hypertension and microalbuminuria.

Authors:  J Redon
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.

Authors:  J R Martens; P Y Reaves; D Lu; M J Katovich; K H Berecek; S P Bishop; M K Raizada; C H Gelband
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 3.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

4.  One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

Authors:  Gaspare Parrinello; Salvatore Paterna; Daniele Torres; Pietro Di Pasquale; Manuela Mezzero; Gabriella La Rocca; Mauro Cardillo; Caterina Trapanese; Mario Caradonna; Giuseppe Licata
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 5.  The kidney as a target of hypertension.

Authors:  S Ljungman
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 6.  The kidney and arterial hypertension.

Authors:  L M Ruilope; C Campo; V Lahera
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Modulation of haemodynamics, endogeneous antioxidant enzymes, and pathophysiological changes by selective inhibition of angiotensin II type 1 receptors in pressureoverload rats.

Authors:  Ghulam Moinuddin; Mohammed Naseeruddin Inamdar; Kala S Kulkarni; Chanda Kulkarni
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.